MAP4K1 and cancer: Moreover, we validated these findings using large‐scale TCGA pan‐cancer data (Figure S19c, Supporting Information), corroborating the results obtained with the experiments and single‐cell RNA‐seq datasets and supporting the therapeutic value of HPK1 in the context of NK cell‐mediated antitumor immunity.